InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Browse the complete record of transactions filed by Davis Aaron I., Director. Insider active across 3 companies, notably Odonate Therapeutics, Inc.. Cumulatively, 7 disclosures have been published. Total volume traded: €5.7m. The latest transaction was disclosed on 9 May 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
€542,05325,000 shares@ €21.682110.7% of flow
Common Stock
SEC:0000899243-22-017712:0·
€4m150,000 shares@ €26.086877.2% of flow
Common Stock
SEC:0000899243-22-016203:0·
€616,25121,300 shares@ €28.93212.2% of flow
Common Stock
SEC:0000899243-22-012152:0·
Ideal exit: 17 Dec 2022 (T+270)
02,546 shares0
Common Stock
SEC:0001214659-22-000842·
02,546 shares0
Common Stock
SEC:0001214659-22-000842:0·
€335,370170,000 shares@ €1.9728100.0% of flow
Common Stock
SEC:0000899243-21-045438·
€335,370170,000 shares@ €1.972850.0% of flow
Common Stock
SEC:0000899243-21-045438:0·
7 of 7 declarations
About Davis Aaron I.
Aaron I. Davis is a Board Member at Odonate Therapeutics, Inc., Mirati Therapeutics, Inc., and iTeos Therapeutics, Inc. As a board member, he brings his expertise in biopharmaceuticals and strategy. His role is to oversee operations and contribute to strategic decision-making that influences the direction of the companies. He is committed to ensuring compliance and transparency within the organizations.
